A new role for the A2b adenosine receptor in regulating platelet function

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 4, 2010, Pages 817-827

  Yang, D ^a   Chen, H ^a   Koupenova, M ^a   Carroll, S H ^a   Eliades, A ^a   Freedman, J E ^a   Toselli, P ^a   Ravid, K ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Platelets; Receptors; Stress; Thrombosis

Indexed keywords

ADENOSINE A2B RECEPTOR; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMORAL ARTERY; GENE EXPRESSION; MALE; MEGAKARYOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN ISOLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; UPREGULATION;

ADENOSINE DIPHOSPHATE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; BLOOD PLATELETS; CELLS, CULTURED; CYCLIC AMP; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; GENOTYPE; INFLAMMATION; LIPOPOLYSACCHARIDES; MEGAKARYOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PLATELET AGGREGATION; RECEPTOR, ADENOSINE A2B; RECEPTORS, PURINERGIC P2; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 77952703085     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03769.x     Document Type: Article

References (40)

1. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003, 23:2131-7.
2. Ruggeri Z. Platelets in atherothrombosis. Nat Med 2002, 8:1227-34.
3. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007, 357:2482-94.
4. Yang J, Wu J, Jiang H, Mortensen R, Austin S, Manning DR, Woulfe D, Brass LF. Signaling through Gi family members in platelets. Redundancy and specificity in the regulation of adenylyl cyclase and other effectors. J Biol Chem 2002, 277:46035-42.
5. Sim DS, Merrill-Skoloff G, Furie BC, Furie B, Flaumenhaft R. Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels. Blood 2004, 103:2127-34.
6. Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963, 168:178-95.
7. Doni MG, Deana R, Bertoncello S, Zoccarato F, Alexandre A. Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses. Biochem Biophys Res Commun 1988, 156:1316-23.
8. Cooper JA, Hill SJ, Alexander SP, Rubin PC, Horn EH. Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets. Br J Clin Pharmacol 1995, 40:43-50.
9. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, Yacoubi ME, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, Parmentier M. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997, 388:674-8.
10. Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea PA. Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation 1999, 99:2499-502.
11. Linden MD, Barnard MR, Frelinger AL, Michelson AD, Przyklenk K. Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models. Thromb Res 2008, 121:689-98.
12. Lupica CR, Cass WA, Zahniser NR, Dunwiddie TV. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Ther 1990, 252:1134-41.
13. Feoktistov I, Biaggioni I. Adenosine A2B receptors. Pharmacol Rev 1997, 49:381-402.
14. Amisten S, Braun O, Bengtsson A, Erlinge D. Gene expression profiling for the identification of G-protein coupled receptors in human platelets. Thromb Res 2008, 122:47-57.
15. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 2006, 116:1913-23.
16. McCrann DJ, Yezefski T, Nguyen HG, Papadantonakis N, Liu H, Wen Q, Crispino JD, Ravid K. Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice. Blood 2008, 111:4092-5.
17. McCrann DJ, Eliades A, Makitalo M, Matsuno K, Ravid K. Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy. Blood 2009, 114:1243-9.
18. Yang D, Koupenova M, McCrann DJ, Kopeikina KJ, Kagan HM, Schreiber BM, Ravid K. The A2b adenosine receptor protects against vascular injury. Proc Natl Acad Sci USA 2008, 105:792-6.
19. Yaar R, Lamperti ED, Toselli PA, Ravid K. Activity of the A3 adenosine receptor gene promoter in transgenic mice: characterization of previously unidentified sites of expression. FEBS Lett 2002, 532:267-72.
20. Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 2003, 19:541-64.
21. St Hilaire C, Koupenova M, Carroll SH, Smith BD, Ravid K. TNF-alpha upregulates the A2B adenosine receptor gene: the role of NAD(P)H oxidase 4. Biochem Biophys Res Commun 2008, 375:292-6.
22. St Hilaire C, Yang D, Schreiber BM, Ravid K. B-Myb regulates the A2B adenosine receptor in vascular smooth muscle cells. J Cell Biochem 2008, 103:1962-74.
23. Hechler B, Toselli P, Ravanat C, Gachet C, Ravid K. Mpl ligand increases P2Y1 receptor gene expression in megakaryocytes with no concomitant change in platelet response to ADP. Mol Pharmacol 2001, 60:1112-20.
24. Hechler B, Zhang Y, Eckly A, Cazenave JP, Gachet C, Ravid K. Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice. J Thromb Haemost 2003, 1:155-63.
25. Hourani S. Purinoceptors and platelet aggregation. J Auton Pharmacol 1996, 16:349-52.
26. Haslam RJ, Rosson GM. Effects of adenosine on levels of adenosine cyclic 3′,5′-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. Mol Pharmacol 1975, 11:528-44.
27. Murphree LJ, Sullivan GW, Marshall MA, Linden J. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. Biochem J 2005, 391:575-80.
28. Coney AM, Marshall JM. Role of adenosine and its receptors in the vasodilatation induced in the cerebral cortex of the rat by systemic hypoxia. J Physiol 1998, 509:507-18.
29. Teng B, Ledent C, Mustafa SJ. Up-regulation of A 2B adenosine receptor in A 2A adenosine receptor knockout mouse coronary artery. J Mol Cell Cardiol 2008, 44:905-14.
30. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 2006, 20:2242-50.
31. Eckle T, Grenz A, Laucher S, Eltzschig HK. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 2008, 118:3301-15.
32. Grenz A, Osswald H, Eckle T, Yang D, Zhang H, Tran ZV, Klingel K, Ravid K, Eltzschig HK. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PloS Med 2008, 5:e137.
33. Kolachala V, Asamoah V, Wang L, Obertone TS, Ziegler TR, Merlin D, Sitaraman SV. TNF-alpha upregulates adenosine 2b (A2b) receptor expression and signaling in intestinal epithelial cells: a basis for A2bR overexpression in colitis. Cell Mol Life Sci 2005, 62:2647-57.
34. Woulfe D, Yang J, Brass L. ADP and platelets: the end of the beginning. J Clin Invest 2001, 107:1503-5.
35. Gachet C. P2 receptors, platelet function and pharmacological implications. Thromb Haemost 2008, 99:466-72.
36. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999, 5:1199-202.
37. Nurden P, Savi P, Heilmann E, Bihour C, Herbert JM, Maffrand JP, Nurden A. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J Clin Invest 1995, 95:1612-22.
38. Hechler B, Leon C, Vial C, Vigne P, Frelin C, Cazenave JP, Gachet C. The P2Y1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation. Blood 1998, 92:152-9.
39. Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Gachet C. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 1999, 104:1731-7.
40. Sachs UJ, Nieswandt B. In vivo thrombus formation in murine models. Circ Res 2007, 100:979-91.